The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

por van Hoogstraten, Willem Sebastiaan, MaassenVanDenBrink, Antoinette
Publicado 2019

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”

por Haanes, Kristian Agmund, Chan, Ka Yi, MaassenVanDenBrink, Antoinette
Publicado 2016

The potential danger of blocking CGRP for treating migraine in CADASIL patients

por de Boer, Irene, MaassenVanDenBrink, Antoinette, Terwindt, Gisela M
Publicado 2020

Protective effects of PACAP in ischemia

por Reglodi, Dora, Vaczy, Alexandra, Rubio-Beltran, Eloísa, MaassenVanDenBrink, Antoinette
Publicado 2018

Headache medication and the COVID-19 pandemic

por MaassenVanDenBrink, Antoinette, de Vries, Tessa, Danser, A. H. Jan
Publicado 2020

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds

por Grände, Gustaf, Labruijere, Sieneke, Haanes, Kristian Agmund, MaassenVanDenBrink, Antoinette, Edvinsson, Lars
Publicado 2014

Gender aspects of CGRP in migraine

por Labastida-Ramírez, Alejandro, Rubio-Beltrán, Eloísa, Villalón, Carlos M, MaassenVanDenBrink, Antoinette
Publicado 2017

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus

por Rivera-Mancilla, Eduardo, Al-Hassany, Linda, Villalón, Carlos M., MaassenVanDenBrink, Antoinette
Publicado 2021

Could erectile dysfunction be a side effect of CGRP inhibition? A case report

por Al-Hassany, Linda, de Vries, Tessa, Carpay, Johannes A, MaassenVanDenBrink, Antoinette
Publicado 2021

Revisiting dose-finding of monoclonal antibodies in migraine

por Al-Hassany, Linda, Karsan, Nazia, Lampl, Christian, Goadsby, Peter J., MaassenVanDenBrink, Antoinette
Publicado 2023

Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms

por González-Hernández, Abimael, Marichal-Cancino, Bruno A., MaassenVanDenBrink, Antoinette, Villalón, Carlos M.
Publicado 2023

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

por MaassenVanDenBrink, Antoinette, Terwindt, Gisela M., van den Maagdenberg, Arn M. J. M.
Publicado 2018

Jealousy in women with migraine: a cross-sectional case-control study

por van Casteren, Daphne S., van Willigenburg, Florine A. C., MaassenVanDenBrink, Antoinette, Terwindt, Gisela M.
Publicado 2020

Giving Researchers a Headache – Sex and Gender Differences in Migraine

por Al-Hassany, Linda, Haas, Jennifer, Piccininni, Marco, Kurth, Tobias, Maassen Van Den Brink, Antoinette, Rohmann, Jessica L.
Publicado 2020

Sex differences in prevalence of migraine trigger factors: A cross-sectional study

por van Casteren, Daphne S, Verhagen, Iris E, Onderwater, Gerrit LJ, MaassenVanDenBrink, Antoinette, Terwindt, Gisela M
Publicado 2020

Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α(2)-adrenoceptors and 5-HT(1) receptors

por González-Hernández, Abimael, Lozano-Cuenca, Jair, Marichal-Cancino, Bruno A., MaassenVanDenBrink, Antoinette, Villalón, Carlos M.
Publicado 2018

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study

por de Vries Lentsch, Simone, van der Arend, Britt W.H., Maassen VanDenBrink, Antoinette, Terwindt, Gisela M.
Publicado 2022

Blocking the CGRP Receptor: Differences across Human Vascular Beds

por de Vries, Tessa, Boucherie, Deirdre M., van den Bogaerdt, Antoon, Danser, A. H. Jan, MaassenVanDenBrink, Antoinette
Publicado 2023

Pain perception in women with menstrually-related migraine

por Linstra, Katie M, Ibrahimi, Khatera, van Casteren, Daphne S, Wermer, Marieke JH, Terwindt, Gisela M, MaassenVanDenBrink, Antoinette
Publicado 2020

Serum CGRP in migraine patients using erenumab as preventive treatment

por de Vries Lentsch, Simone, Garrelds, Ingrid M., Danser, A. H. Jan, Terwindt, Gisela M., MaassenVanDenBrink, Antoinette
Publicado 2022